Pressure-overload cardiac hypertrophy is associated with distinct alternative splicing due to altered expression of

Taeyong Kim1, Jin Ock Kim, Jae Gyun Oh

  • 1School of Life Sciences and Systems Biology Research Center, Gwangju Institute of Science and Technology, Gwangju 500-712, Korea.

Molecules and Cells
|February 21, 2014
PubMed

Insights

Alternative splicing alterations are linked to cardiac hypertrophy. This study identified specific RNA splicing regulatory elements and altered splicing factors (ESRP1, PTB, SF2/ASF) in pressure-overload cardiac hypertrophy.

Area of Science:

  • Molecular Biology
  • Cardiovascular Biology
  • Genomics

Background:

  • Chronic pressure-overload cardiac hypertrophy increases morbidity and mortality risk.
  • This condition involves maladaptive remodeling and dilatation, potentially leading to dilated cardiomyopathy.
  • Alternative splicing generates proteomic diversity but its role in cardiac hypertrophy remains unclear.

Purpose of the Study:

  • To investigate the role of alternative splicing in pressure-overload cardiac hypertrophy.
  • To identify RNA splicing regulatory elements involved in this process.
  • To determine changes in splicing factor expression during cardiac hypertrophy.

Main Methods:

  • RNA sequencing (RNA-Seq) and bioinformatic analysis were employed.
  • Identification of exonic and intronic motifs regulating alternative splicing.
  • Western blotting was used to assess splicing factor expression.

Main Results:

  • GC-rich exonic motifs were found to regulate intron retention in 5' UTRs.
  • AT-rich exonic motifs were identified in 3' UTRs, influencing mRNA stability.
  • Intronic motifs involved in exon splicing were detected, predicting binding of specific splicing factors.
  • Expression levels of ESRP1, PTB, and SF2/ASF were significantly altered.

Conclusions:

  • Pressure-overload cardiac hypertrophy is associated with distinct alternative splicing patterns.
  • Altered expression of splicing factors contributes to these splicing changes.
  • This research provides insights into the molecular mechanisms of cardiac remodeling.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.3K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

4.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K